Polyethylene glycol is used to treat constipation by drawing water into the intestines to soften stool and make bowel movements easier. It's also used to cleanse the colon before medical procedures like colonoscopies.[2] GoLYTELY is currently approved and in use across 21 indications[4].[1]
GoLYTELY is one of 472 small molecule programs targeting Peripheral Nerve Injury. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
797 competitors in Hepatocellular Carcinoma
GoLYTELY
Cysteine Hydrochloride
Coreg
Miraclid
Vermox
Apatinib
Doptelet
PD-1 Inhibitor
Statin
PD-1 Inhibitors
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Oct 6, 2006
MIRALAX
NDA NDA022015
Sources